LUO Piao, CHU Shi-feng, GAO Yan, LUO Lin-ming, PENG Lan, CHEN Nai-hong. Advances in study of pharmacological effects of ginsenoside Rg1 in hepatic diseasesJ. Acta Pharmaceutica Sinica, 2018,53(1): 21-27. doi: 10.16438/j.0513-4870.2017-0578
Citation: LUO Piao, CHU Shi-feng, GAO Yan, LUO Lin-ming, PENG Lan, CHEN Nai-hong. Advances in study of pharmacological effects of ginsenoside Rg1 in hepatic diseasesJ. Acta Pharmaceutica Sinica, 2018,53(1): 21-27. doi: 10.16438/j.0513-4870.2017-0578

Advances in study of pharmacological effects of ginsenoside Rg1 in hepatic diseases

  • Ginsenoside Rg1 is one of the main active components of ginseng with various pharmacological activities including anti-inflammatory, anti-oxidation, anti-aging, anti-tumor and anti-apoptosis. Ginsenoside Rg1 plays a protective role in multiple tissues and organs, which shows the multiple targeting properties of the pharmacological effects. Recently, a number of studies have demonstrated that ginsenoside Rg1 has a protective role in the liver due to its multiple pharmacological effects. In chemical liver injury models, or in other liver injury models, ginsenoside Rg1 can alleviate liver necrosis induced by oxidative stress and inflam-mation. This article provides a review of the recent studies on the efficacy of ginsenoside Rg1 in the treatment of various liver damage and the molecular mechanism.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return